SelectImmune Pharma AB

ABDissolved

Org 5591046874Other research and experimental development on natural sciences and engineering· NACE 7219Est. 2017 · 9 years old2 employees

Overview Financials People & ownership Related companies

SelectImmune Pharma AB is a Swedish AB, operating in the Other research and experimental development on natural sciences and engineering sector. Incorporated in 2017, the company has 2 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2023

SEK 0

EBITDA margin

—

Net profit 2023

SEK -8,6M

+39% vs 2022

Key ratios

See full ratios →

61.8%

This company

20192023

2.2×

This company

20192023

-168.1%

This company

20192023

EBITDA — year on year

SEK millions

Frequently asked questions

What is the Org number of SelectImmune Pharma AB?

SelectImmune Pharma AB is registered with Bolagsverket / SCB under Org 5591046874.

How many employees does SelectImmune Pharma AB have?

SelectImmune Pharma AB employs 2 people as of the latest annual report.

Who is the CEO of SelectImmune Pharma AB?

Gabriela Sofia Victoria Godaly is the CEO of SelectImmune Pharma AB, in role since 2020.

Who is the chairman of SelectImmune Pharma AB?

Marianne Catharina Svanborg chairs the board of SelectImmune Pharma AB, in role since 2020.

Revenue	SEK 0	—
EBITDA	SEK -8,2M	+40%
Net profit	SEK -8,6M	+39%
Total assets	SEK 5,1M	-61%
Equity	SEK 3,2M	-73%
Employees	2	—

SelectImmune Pharma AB

Key ratios

EBITDA — year on year

Company information

Frequently asked questions

More on SelectImmune Pharma AB

Key ratios

EBITDA — year on year

Company information

Frequently asked questions

More on SelectImmune Pharma AB

Key figures

Contact